ProfileGDS5822 / ILMN_1216195
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 64% 66% 67% 62% 71% 70% 69% 64% 67% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 133.664
GSM1276600PDAC Late Ablation Control 240.466
GSM1276601PDAC Late Ablation Control 358.767
GSM1276602PDAC Late Ablation 128.162
GSM1276603PDAC Late Ablation 259.471
GSM1276604PDAC Late Ablation 358.270
GSM1303940PDAC Late Ablation_anti-CTLA4 143.369
GSM1303941PDAC Late Ablation_anti-CTLA4 243.264
GSM1303942PDAC Late Ablation_anti-CTLA4 357.367